Genopore is developing a semiconductor-based protein detection system that utilizes chip technology for single-molecule analysis, offering high sensitivity and accuracy in proteomics. This technology enables researchers to identify proteins at low concentrations, facilitating early detection of cancer and other diseases.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for protein detection often lack the sensitivity and accuracy needed for early disease detection and comprehensive proteomic analysis. Existing technologies may struggle to identify proteins present at low concentrations, hindering research and diagnostic efforts.
Solution
Genopore is developing a protein detection system leveraging semiconductor chip technology to enable single-molecule analysis. This approach offers enhanced sensitivity and accuracy in proteomics, allowing researchers to identify and quantify proteins, even at low concentrations. By utilizing chip-based technology, Genopore aims to provide a more efficient and precise method for protein analysis, facilitating advancements in disease research and diagnostics.
Target Audience
The primary audience includes researchers and diagnostic labs focused on proteomics, early disease detection, and biomarker discovery.
Features
- Semiconductor-based chip technology for single-molecule protein detection
- High sensitivity for identifying proteins at low concentrations
- Enhanced accuracy in proteomic analysis